bioRxivCancer BiologyPreprint
Cellular landscape of adrenocortical carcinoma at single-nuclei resolution
D. S. Tourigny, B. Altieri, K. A. Secener, S. Sbiera, M. P. Schauer, P. Arampatzi, S. Herterich, S. S. Sauer, M. Fassnacht, C. L. Ronchi
Abstract
Adrenocortical carcinoma (ACC) is a rare yet devastating tumour of the adrenal gland with a molecular pathology that remain incompletely understood. To gain novel insights into the cellular landscape of ACC, we generated single-nuclei RNA sequencing (snRNA-seq) data sets from twelve ACC tumour samples and analysed these alongside a previously published snRNA-seq data set from normal adrenal glands (NAGs). We find the ACC tumour microenvironment to be relatively devoid of immune cells compared to NAG tissues, consistent with known high tumour purity values for ACC as an immunologically "cold" tumour. Our analysis identifies three separate groups of ACC samples that are characterised by different relative compositions of adrenocortical cell types, including two populations (ACC 1 and ACC 2) that are specifically enriched in the most aggressive tumours and display hallmarks of the epithelial to mesenchymal transition (EMT) and dysregulated steroidogenesis, respectively. In addition to cell types associated with hypoxic and metabolic signatures (ACC 3 and ACC 4) prevalent among less-aggressive tumours, we also identified and validated a population of mitotically active adrenocortical cells (ACC M) strongly overexpressing genes POLQ and DIAPH3 that possibly supports the expansion of malignant cell lineages. The smallest identified ACC specific cell type, ACC 5, displays characteristics of increased proliferation and growth factor signalling, and is therefore a potential progenitor-like or cell-of-origin candidate for the different lineages involved in adrenocortical carcinogenesis. Intriguingly, linage tracing suggests the fate adopted by malignant adrenocortical cells upon differentiation appears to be at least partly associated with the copy number or allelic balance state of the imprinted DLK1/MEG3 genomic locus, which we verified by assessing DNA methylation status among samples from the three groups of tumours defined by their different cell type compositions. Our results therefore provide new insights into the cellular heterogeneity of ACC, indicating that genetic perturbations to a hierarchical cellular differentiation mechanism underlying healthy adrenocortical renewal and zonation may explain the molecular basis for disease pathogenesis.
- organism: human
- assay: snRNA-seq
- research focus: cell type annotation
- research focus: clustering
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single Nuclei Sequencing Reveals Replication Stress in Adrenocortical Carcinoma
Liudmila V. Popova, Elizabeth A. R. Garfinkle, … Priya H. Dedhia·bioRxiv·Sep 30, 2024
- Cell Atlas at Single-Nuclei Resolution of the Adult Human Adrenal Gland and Adrenocortical Adenomas
B. Altieri, K. Secener, … S. Sauer·bioRxiv·Aug 27, 2022
- Establishment of a patient-derived adrenocortical carcinoma 3D tumor construct platform for evaluation of therapeutic strategies
Marco A. Rodriguez, Hemamylammal Sivakumar, … Aleksander Skardal·bioRxiv·Jan 9, 2026
- Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma
Katia Mariniello, James F. H. Pittaway, … Leonardo Guasti·癌症:英文版Peer-reviewed·Mar 4, 2025
- The super-enhancer landscape reflects molecular subgroups of adrenocortical carcinoma
S. Gunz, G. Kerdivel, … V. Boeva·bioRxiv·Apr 5, 2023
- Updating ACC preclinical models: characterization of two new patient-derived cell lines
Andrea Abate, Mariangela Tamburello, … Sandra Sigala·Endocrine Related CancerPeer-reviewed·May 1, 2026